What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Diffuse Large B-Cell Lymphoma

Featuring perspectives from Dr Christopher R Flowers, Ms Amy Goodrich, Ms Robin Klebig and Dr Matthew Lunning, including the following topics:

• Introduction (0:00)
• POLARIX: Polatuzumab Vedotin/R-CHP for Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) (5:55)
• Polatuzumab Vedotin/Bendamustine/Rituximab and Selinexor for Relapsed Disease (24:28)
• CD19-Directed Antibody-Drug Conjugate Loncastuximab Tesirine (42:43)
• CD19-Directed Monoclonal Antibody Tafasitamab Combined with Lenalidomide (51:16)
• CD20 x CD3 Bispecific Antibodies (1:01:02)
• CAR (Chimeric Antigen Receptor) T-Cell Therapy (1:19:07)

NCPD information and select publications